子宫颈低级别鳞状上皮内病变管理的中国专家共识

2022-07-15 北京大学第一医院妇产科 中国妇产科临床杂志

本共识中阐释了子宫颈低级别鳞状上皮内病变的概念、转归、阴道镜评估的意义、管理流程等相关问题。规范子宫颈低级别鳞状上皮内病变的管理,以指导临床实践,并避免对其过度干预及诊断中高级别上皮内病变的漏诊。

中文标题:

子宫颈低级别鳞状上皮内病变管理的中国专家共识

发布日期:

2022-07-15

简要介绍:

子宫颈低级别鳞状上皮内病变(LSIL)多为人乳头瘤病毒(HPV)一过性感染引起临床及病理形态学改变的一种鳞状上皮内病变,有较高的逆转率,合并或进展到浸润癌的风险极低。中国优生科学协会阴道镜和宫颈病理学分会(CSCCP)专家组结合国内外最新进展和中国国情,制定了本共识。共识中阐释了子宫颈低级别鳞状上皮内病变的概念、转归、阴道镜评估的意义、管理流程等相关问题。规范子宫颈低级别鳞状上皮内病变的管理,以指导临床实践,并避免对其过度干预及诊断中高级别上皮内病变的漏诊。

相关资料下载:
[AttachmentFileName(sort=1, fileName=子宫颈低级别鳞状上皮内病变管理的中国专家共识_毕蕙.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7fe461c002533e4d, title=子宫颈低级别鳞状上皮内病变管理的中国专家共识, enTitle=, guiderFrom=中国妇产科临床杂志, authorId=0, author=, summary=本共识中阐释了子宫颈低级别鳞状上皮内病变的概念、转归、阴道镜评估的意义、管理流程等相关问题。规范子宫颈低级别鳞状上皮内病变的管理,以指导临床实践,并避免对其过度干预及诊断中高级别上皮内病变的漏诊。, cover=https://img.medsci.cn/Random/diagnostic-form-in-hospital-conceptual-image-7JAH3GT.jpg, journalId=0, articlesId=null, associationId=2957, associationName=北京大学第一医院妇产科, associationIntro=北京大学第一医院妇产科, copyright=0, guiderPublishedTime=Fri Jul 15 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">子宫颈低级别鳞状上皮内病变(LSIL)多为人乳头瘤病毒(HPV)一过性感染引起临床及病理形态学改变的一种鳞状上皮内病变,有较高的逆转率,合并或进展到浸润癌的风险极低。中国优生科学协会阴道镜和宫颈病理学分会(CSCCP)专家组结合国内外最新进展和中国国情,制定了本共识。共识中阐释了子宫颈低级别鳞状上皮内病变的概念、转归、阴道镜评估的意义、管理流程等相关问题。规范子宫颈低级别鳞状上皮内病变的管理,以指导临床实践,并避免对其过度干预及诊断中高级别上皮内病变的漏诊。</span></p>, tagList=[TagDto(tagId=1841, tagName=中国专家共识), TagDto(tagId=51465, tagName=子宫颈上皮内瘤变)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=51465, articleKeyword=子宫颈上皮内瘤变, articleKeywordNum=6, guiderKeywordId=1841, guiderKeyword=中国专家共识, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2985, appHits=165, showAppHits=0, pcHits=903, showPcHits=2815, likes=2, shares=36, comments=5, approvalStatus=1, publishedTime=Fri Jul 22 10:32:00 CST 2022, publishedTimeString=2022-07-15, pcVisible=1, appVisible=1, editorId=0, editor=lixiang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=lixiang, createdTime=Tue Jul 19 10:10:49 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 20:32:43 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=子宫颈低级别鳞状上皮内病变管理的中国专家共识_毕蕙.pdf)])
子宫颈低级别鳞状上皮内病变管理的中国专家共识_毕蕙.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2094647, encodeId=99f3209464e15, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00038142021, createdName=ms3000000848423424, createdTime=Wed Oct 19 08:29:51 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235844, encodeId=9ad3123584465, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b08256125, createdName=ms2000000554128174, createdTime=Mon Aug 01 03:03:28 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235044, encodeId=0fb9123504473, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c8f5422478, createdName=ms2000001537418416, createdTime=Wed Jul 27 13:19:51 CST 2022, time=2022-07-27, status=1, ipAttribution=)]
    2022-10-19 ms3000000848423424

    学习一下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2094647, encodeId=99f3209464e15, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00038142021, createdName=ms3000000848423424, createdTime=Wed Oct 19 08:29:51 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235844, encodeId=9ad3123584465, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b08256125, createdName=ms2000000554128174, createdTime=Mon Aug 01 03:03:28 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235044, encodeId=0fb9123504473, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c8f5422478, createdName=ms2000001537418416, createdTime=Wed Jul 27 13:19:51 CST 2022, time=2022-07-27, status=1, ipAttribution=)]
    2022-08-01 ms2000000554128174

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2094647, encodeId=99f3209464e15, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00038142021, createdName=ms3000000848423424, createdTime=Wed Oct 19 08:29:51 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235844, encodeId=9ad3123584465, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09b08256125, createdName=ms2000000554128174, createdTime=Mon Aug 01 03:03:28 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235044, encodeId=0fb9123504473, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c8f5422478, createdName=ms2000001537418416, createdTime=Wed Jul 27 13:19:51 CST 2022, time=2022-07-27, status=1, ipAttribution=)]
    2022-07-27 ms2000001537418416

    0

拓展阅读

JCO:子宫颈上皮内瘤变Ⅲ级者,其它部位的HPV相关肿瘤风险长期持续增加

子宫颈上皮内瘤变(cervical intraepithelial neoplasia CIN):将子宫颈上皮非典型增生至原位癌这一系列癌前病变的连续过程称为子宫颈上皮内瘤变。根据细胞改变程度和异型细胞范围可将CIN分为三级:Ⅰ级为轻度不典型增生,不典型细胞局限于上皮下1/3;Ⅱ级为中度不典型增生,不典型细胞主要位于上皮下1/3~2/3层,细胞极性尚存;Ⅲ级为重度不典型增生和(或)原位癌,病变细胞

尘肺病肺康复中国专家共识(2022 年版)

中华预防医学会(CPMA,Chinese Preventive Medicine Association) · 2022-06-28

创伤性出血患者血液管理专家共识(2022年版)

中国输血协会临床输血学专业委员会 · 2022-06-30

医院主导的家庭心脏康复中国专家共识

中国康复医学会心血管病专业委员会 ·

人工肝血液净化技术临床应用专家共识(2022 年版)

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2022-04-15

肥胖症中医诊疗方案专家共识(更新)

中华中医药学会《中医体重管理临床指南》专家组 · 2022-08-24